Continuous flow teriflunomide preparation process
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 河北凯威恒诚制药有限公司
- Publication Date
- 2021-11-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
Technical field
[0001] The present invention relates to the field of chemical synthesis, and more particularly to a process of continuous fluorine amine. Background technique
[0002] Teriflunomide, Chemical Name: (Z) -2-cyano-3-hydroxy-N- [4- (trifluoromethyl) phenyl] -2-butenamide. Tripfluorine is an oral pyrimidine synthase inhibitor and an immunomodulator developed by French Sanopi Avante, which can reverse the inhibitory dihydrochloric acid dehydrogenase (DHODH) - related to the primary synthesis A key enzyme. DHODH is a mitochondrase containing iron-free plain-dependent mitochromese, a critical enzyme in nucleic acid, catalyzed pyrimidine from the fourth step in the head biosynthesis pathway. DHODH is an important target of immune-related diseases, inhibiting DHODH, preventing neonatizine synthesis, causing DNA synthesis disorder, inhibiting activated T lymphocytes, B lymphocytes, and tumor cell proliferation, thereby plays importance in immunosuppression and anti-tumor eff...